Stem Cells
Therapies
Stem Cells Therapies
The purpose of banking stem cells is to apply them in the therapy. For the first time cord blood was used in 1988 and since then according to publicly available statistics it has been used over 85 000 times worldwide (including statistics of China).
FamiCord Group stores over 1,000,000 samples of cells of different types and has supplied stem cells for application in clinic for more than 7000 patients. We supply stem cells for standard transplantations (cord blood , bone marrow and mobilized peripheral blood) and cellular therapies. On top of that we provide cell based products in GMP standard for clinical trials.
Stem cells manufactured in our premises helped patients with various diseases and therapeutic areas, including haematological, neurological, ophthalmological, orthopaedical, dermatological disorders.
Check the full list of patients who received stem cell therapy derived from FamiCord labs.
List last update: 06.2026
List of patients who received stem cells from FamiCord Group laboratories
| Lp. | Source | Source type | Diagnosis | Medical field | Year of application | Therapy | Country | Age of recipient |
|---|---|---|---|---|---|---|---|---|
| 2101 | Bone Marrow Family | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 76 |
| 2102 | Bone Marrow Family | Allogeneic | Langerhans Cell Sarcoma | Hematology | 2023 | Standard Therapy | Poland | 66 |
| 2103 | Bone Marrow Family | Allogeneic | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Poland | 63 |
| 2104 | Bone Marrow Family | Allogeneic | Mycosis Fungoides | Hematology | 2023 | Standard Therapy | Poland | 71 |
| 2105 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 71 |
| 2106 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 68 |
| 2107 | Bone Marrow Family | Allogeneic | Myelofibrosis | Hematology | 2023 | Standard Therapy | Poland | 70 |
| 2108 | Bone Marrow Family | Allogeneic | No Data | Hematology | 2023 | Standard Therapy | Germany | 70 |
| 2109 | Bone Marrow Family | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2023 | Standard Therapy | Poland | 55 |
| 2110 | Bone Marrow Family | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 73 |
| 2111 | Bone Marrow Family | Allogeneic | Secondary Chronic Myelomonocytic Leukemia To Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 62 |
| 2112 | Bone Marrow Family | Allogeneic | Secondary Myelodysplastic Syndrome With Excess Of Blasts | Hematology | 2023 | Standard Therapy | Poland | 15 |
| 2113 | Bone Marrow Family | Allogeneic | Severe Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 71 |
| 2114 | Bone Marrow Family | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 5 |
| 2115 | Bone Marrow | Allogeneic | Acute Leukemia Of Ambiguous Lineage | Hematology | 2023 | Standard Therapy | Poland | 1 |
| 2116 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 11 |
| 2117 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 5 |
| 2118 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 16 |
| 2119 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 28 |
| 2120 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 14 |
| 2121 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 1 |
| 2122 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 25 |
| 2123 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 7 |
| 2124 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 4 |
| 2125 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 8 |
| 2126 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 12 |
| 2127 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 63 |
| 2128 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 5 |
| 2129 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 12 |
| 2130 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 3 |
| 2131 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 49 |
| 2132 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 14 |
| 2133 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 47 |
| 2134 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 11 |
| 2135 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 13 |
| 2136 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 17 |
| 2137 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 32 |
| 2138 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 43 |
| 2139 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 12 |
| 2140 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 59 |
| 2141 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 38 |
| 2142 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 14 |
| 2143 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 1 |
| 2144 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 75 |
| 2145 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 55 |
| 2146 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 13 |
| 2147 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 6 |
| 2148 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 17 |
| 2149 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 34 |
| 2150 | Bone Marrow | Allogeneic | Adrenoleukodystrophy | Hematology | 2023 | Standard Therapy | Poland | 7 |
| 2151 | Bone Marrow | Allogeneic | Adrenoleukodystrophy (Ald) – Siemerling-Creutzfeldt Disease | Hematology | 2023 | Standard Therapy | Poland | 4 |
| 2152 | Bone Marrow | Allogeneic | Amegakaryocytic Thrombocytopenia | Hematology | 2023 | Standard Therapy | Poland | 6 |
| 2153 | Bone Marrow | Allogeneic | Anemia Fanconi | Hematology | 2023 | Standard Therapy | Poland | 6 |
| 2154 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 18 |
| 2155 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 43 |
| 2156 | Bone Marrow | Allogeneic | B-Cell Precursor Acute Lymphocytic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 12 |
| 2157 | Bone Marrow | Allogeneic | Chronic Granulomatous Disease | Hematology | 2023 | Standard Therapy | Poland | 12 |
| 2158 | Bone Marrow | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2023 | Standard Therapy | Poland | 55 |
| 2159 | Bone Marrow | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2023 | Standard Therapy | Poland | 57 |
| 2160 | Bone Marrow | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2023 | Standard Therapy | Poland | 40 |
| 2161 | Bone Marrow | Allogeneic | Chronic Myeloid Leukemia Blast Crisis | Hematology | 2023 | Standard Therapy | Poland | 21 |
| 2162 | Bone Marrow | Allogeneic | Clippers Syndrome | Hematology | 2023 | Standard Therapy | Poland | 49 |
| 2163 | Bone Marrow | Allogeneic | Congenital Amegakaryocytic Thrombocytopenia (Camt) | Hematology | 2023 | Standard Therapy | Poland | 6 |
| 2164 | Bone Marrow | Allogeneic | Fanconi Anemia | Hematology | 2023 | Standard Therapy | Poland | 8 |
| 2165 | Bone Marrow | Allogeneic | Hemophagocytic Lymphohistiocytosis (Hlh) | Hematology | 2023 | Standard Therapy | Poland | 2 |
| 2166 | Bone Marrow | Allogeneic | Hodgkin’s Lymphoma | Hematology | 2023 | Standard Therapy | Poland | 23 |
| 2167 | Bone Marrow | Allogeneic | Immunodeficiency – Xlp1 | Hematology | 2023 | Standard Therapy | Poland | 10 |
| 2168 | Bone Marrow | Allogeneic | Juvenile Myelomonocytic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 5 |
| 2169 | Bone Marrow | Allogeneic | Mantle Cell Lymphoma | Hematology | 2023 | Standard Therapy | Poland | 68 |
| 2170 | Bone Marrow | Allogeneic | Metachromatic Leukodystrophy | Hematology | 2023 | Standard Therapy | Poland | 22 |
| 2171 | Bone Marrow | Allogeneic | Mitochondrial Neurogastrointestinal Encephalopathy | Hematology | 2023 | Standard Therapy | Poland | 33 |
| 2172 | Bone Marrow | Allogeneic | Mixed Lineage Acute Leukemia | Hematology | 2023 | Standard Therapy | Poland | 4 |
| 2173 | Bone Marrow | Allogeneic | Monocytopenia And Mycobacterial Infection (Monomac) Syndrome | Hematology | 2023 | Standard Therapy | Poland | 5 |
| 2174 | Bone Marrow | Allogeneic | Mucopolysaccharidosis Type I | Hematology | 2023 | Standard Therapy | Poland | 2 |
| 2175 | Bone Marrow | Allogeneic | Mucopolysaccharidosis Type IH (Hurler) | Hematology | 2023 | Standard Therapy | Poland | 8 |
| 2176 | Bone Marrow | Allogeneic | Mucopolysaccharidosis Type Iv | Hematology | 2023 | Standard Therapy | Poland | 5 |
| 2177 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 51 |
| 2178 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 11 |
| 2179 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 14 |
| 2180 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 6 |
| 2181 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 7 |
| 2182 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 19 |
| 2183 | Bone Marrow | Allogeneic | No Data | Hematology | 2023 | Standard Therapy | Poland | 3 |
| 2184 | Bone Marrow | Allogeneic | No Data | Hematology | 2023 | Standard Therapy | Poland | 2 |
| 2185 | Bone Marrow | Allogeneic | No Data | Hematology | 2023 | Standard Therapy | Poland | 61 |
| 2186 | Bone Marrow | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2023 | Standard Therapy | Poland | 20 |
| 2187 | Bone Marrow | Allogeneic | Other Immune System | Hematology | 2023 | Standard Therapy | Poland | 6 |
| 2188 | Bone Marrow | Allogeneic | Other Immune System | Hematology | 2023 | Standard Therapy | Poland | 6 |
| 2189 | Bone Marrow | Allogeneic | Primary Combined Severe Immunodeficiency | Hematology | 2023 | Standard Therapy | Poland | 14 |
| 2190 | Bone Marrow | Allogeneic | Primary Immunodeficiency | Hematology | 2023 | Standard Therapy | Poland | 3 |
| 2191 | Bone Marrow | Allogeneic | Primary Immunodeficiency | Hematology | 2023 | Standard Therapy | Poland | 4 |
| 2192 | Bone Marrow | Allogeneic | Prolymphocytic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 55 |
| 2193 | Bone Marrow | Allogeneic | Relapsed T Cell Acute Lymphoblastic Leukemia (T-All) | Hematology | 2023 | Standard Therapy | Poland | 5 |
| 2194 | Bone Marrow | Allogeneic | Secondary Leukemia | Hematology | 2023 | Standard Therapy | Poland | 20 |
| 2195 | Bone Marrow | Allogeneic | Secondary Myelofibrosis Post Polycythemia Vera | Hematology | 2023 | Standard Therapy | Poland | 60 |
| 2196 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 11 |
| 2197 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 4 |
| 2198 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 31 |
| 2199 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 49 |
| 2200 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 8 |